KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2021 Jun 30

PMID 34188523

Citations 12

Authors

Yuexian Li

Zhou Su

Biwei Wei

Zhihai Liang

Affiliations

Soon will be listed here.

Abstract

Background: Pancreatic adenocarcinoma (PAAD) is a deadly tumor with a high recurrence rate and poor prognosis. Keratin 7 (KRT7) is a member of the keratin gene family that is involved in the regulation of cell growth, migration and apoptosis in many cancers. However, the role of KRT7 and its biological functions in PAAD remain unclear. We systemically analyzed the expression and clinical values of KRT7 in PAAD.

Methods: The Gene Expression Profiling Interactive Analysis (GEPIA), Oncomine and Human Protein Atlas (HPA) databases were used to analyze the mRNA and protein expression of KRT7 in PAAD. The prognosis and subgroup analysis of KRT7 in PAAD patients was performed using the GEPIA, PROGgeneV2 and UALCAN databases. Later, the correlation between KRT7 expression and tumor immune molecules in PAAD was evaluated using the Immune Cell Abundance Identifier (ImmuCellAI) and TISIDB databases. Finally, the functional enrichment pathway of KRT7 and its coexpressed genes were analyzed by the Database for Annotation, Visualization, and Integrated Discovery (DAVID) and Metascape databases and Gene Set Enrichment Analysis (GSEA).

Results: The mRNA and protein expression of KRT7 was increased in PAAD tissues compared with normal tissues. High KRT7 expression was closely associated with tumor grade, TP53 mutations and poor prognosis in PAAD patients. Cox regression analysis proved that overexpressed KRT7 was an important and independent risk factor for poor overall survival (P = 0.006, HR =1.87) and disease-free survival (P = 0.019, HR =1.793) in PAAD. Additionally, KRT7 expression was significantly associated with immune infiltration of tumor immune cells and immunomodulators. Functional enrichment analyses and GSEA indicated that KRT7 might be involved in the regulation of the p53 pathway in PAAD.

Conclusion: Overexpressed KRT7 could be a promising prognostic and therapeutic target biomarker for PAAD by bioinformatics analysis.

Citing Articles

KRT7 promotes pancreatic cancer metastasis by remodeling the extracellular matrix niche through FGF2-fibroblast crosstalk.

Jiang Y, Liao C, Lai J, Peng Y, Chen Q, Zheng X Sci Rep. 2025; 15(1):6951.

PMID: 40011455 PMC: 11865440. DOI: 10.1038/s41598-024-84129-1.

Genetic factors underlying Mandibular prognathism: insights from recent human and animal studies.

Fang H, Li P, Zhu S, Bi R Mamm Genome. 2024; 36(1):293-305.

PMID: 39607497 DOI: 10.1007/s00335-024-10084-x.

Single-cell transcriptome analysis identifies subclusters and signature with N-glycosylation in endometrial cancer.

Zhou M, Zhang Y, Song W Clin Transl Oncol. 2024; .

PMID: 39589706 DOI: 10.1007/s12094-024-03802-z.

Comprehensive analysis of RNA-5-methylcytosine modification in breast cancer brain metastasis.

Cai P, Li J, An M, Li M, Guo J, Li J Future Oncol. 2024; 20(37):2993-3008.

PMID: 39345093 PMC: 11572191. DOI: 10.1080/14796694.2024.2405459.

A Comprehensive Review of Protein Biomarkers for Invasive Lung Cancer.

Mezentsev A, Durymanov M, Makarov V Curr Oncol. 2024; 31(9):4818-4854.

PMID: 39329988 PMC: 11431409. DOI: 10.3390/curroncol31090360.

References

Schussler M, Skoudy A, Ramaekers F, Real F . Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol. 1992; 140(3):559-68. PMC: 1886166. View

Luo H, Liang C, Luo R, Gu W . Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer. Biosci Rep. 2017; 37(6). PMC: 5672087. DOI: 10.1042/BSR20171086. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Murter B, Pan X, Ophir E, Alteber Z, Azulay M, Sen R . Mouse PVRIG Has CD8 T Cell-Specific Coinhibitory Functions and Dampens Antitumor Immunity. Cancer Immunol Res. 2019; 7(2):244-256. PMC: 7038785. DOI: 10.1158/2326-6066.CIR-18-0460. View

Kvederaviciute K, Meskinyte I, Meskinyte-Kausiliene E, Skeberdyte A, Cicenas J . KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer. Cancers (Basel). 2017; 9(5). PMC: 5447952. DOI: 10.3390/cancers9050042. View

Jacob J, Coulombe P, Kwan R, Omary M . Types I and II Keratin Intermediate Filaments. Cold Spring Harb Perspect Biol. 2018; 10(4). PMC: 5880164. DOI: 10.1101/cshperspect.a018275. View

Hegde S, Krisnawan V, Herzog B, Zuo C, Breden M, Knolhoff B . Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell. 2020; 37(3):289-307.e9. PMC: 7181337. DOI: 10.1016/j.ccell.2020.02.008. View

Stamm H, Klingler F, Grossjohann E, Muschhammer J, Vettorazzi E, Heuser M . Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option. Oncogene. 2018; 37(39):5269-5280. PMC: 6160395. DOI: 10.1038/s41388-018-0288-y. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

10.

Goswami C, Nakshatri H . PROGgeneV2: enhancements on the existing database. BMC Cancer. 2014; 14:970. PMC: 4300843. DOI: 10.1186/1471-2407-14-970. View

11.

McGuigan A, Kelly P, Turkington R, Jones C, Coleman H, McCain R . Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018; 24(43):4846-4861. PMC: 6250924. DOI: 10.3748/wjg.v24.i43.4846. View

12.

Kudo-Saito C, Ozaki Y, Imazeki H, Hayashi H, Masuda J, Ozawa H . Targeting Oncoimmune Drivers of Cancer Metastasis. Cancers (Basel). 2021; 13(3). PMC: 7867187. DOI: 10.3390/cancers13030554. View

13.

Wang Z, Zhao J, Zhao H, A S, Liu Z, Zhang Y . Infiltrating CD4/CD8 high T cells shows good prognostic impact in pancreatic cancer. Int J Clin Exp Pathol. 2020; 10(8):8820-8828. PMC: 6965435. View

14.

Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov J . GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics. 2007; 23(23):3251-3. DOI: 10.1093/bioinformatics/btm369. View

15.

Allard B, Longhi M, Robson S, Stagg J . The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol Rev. 2017; 276(1):121-144. PMC: 5338647. DOI: 10.1111/imr.12528. View

16.

Lee H, Leem G, Kang H, Jo J, Chung M, Jang S . Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol. 2020; 36(2):516-522. DOI: 10.1111/jgh.15265. View

17.

Nizri E, Bar-David S, Aizic A, Sternbach N, Lahat G, Wolf I . Desmoplasia in Lymph Node Metastasis of Pancreatic Adenocarcinoma Reveals Activation of Cancer-Associated Fibroblasts Pattern and T-helper 2 Immune Cell Infiltration. Pancreas. 2019; 48(3):367-373. DOI: 10.1097/MPA.0000000000001261. View

18.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

19.

von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B . STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003; 31(1):258-61. PMC: 165481. DOI: 10.1093/nar/gkg034. View

20.

Cai B, Hsu P, Hsin I, Chao C, Lu M, Lin H . p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation. PLoS One. 2012; 7(7):e41742. PMC: 3404013. DOI: 10.1371/journal.pone.0041742. View